^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

FGF7 (Fibroblast Growth Factor 7)

i
Other names: FGF7, Fibroblast Growth Factor 7, KGF, Keratinocyte Growth Factor, Heparin-Binding Growth Factor 7, HBGF-7, FGF-7, Fibroblast Growth Factor 7 (Keratinocyte Growth Factor)
Associations
Trials
11d
Activated Human Pancreatic Stellate Cells Signature Communication in Type 1 Diabetes. (PubMed, Res Sq)
Conclusions Our study revealed novel intercellular communication signatures involving aPSCs in T1D. Identification of the changes in cellular communication between aPSCs and other cells in T1D suggest a role in T1D pathogenesis or progression which might lead to the development of novel therapeutics.
Journal
|
CXCL12 (C-X-C Motif Chemokine Ligand 12) • TGFB1 (Transforming Growth Factor Beta 1) • FGF7 (Fibroblast Growth Factor 7)
1m
Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial. (PubMed, JMIR Res Protoc)
The results of this study may help develop an effective treatment for EGFR-TKI-mediated rashes. The findings will be published in academic journals upon the completion of the trial.
Clinical protocol • Journal
|
EGFR (Epidermal growth factor receptor) • HGF (Hepatocyte growth factor) • FGF7 (Fibroblast Growth Factor 7)
|
EGFR mutation
3ms
Influence of Surface Functional Groups on the Hair Growth-Promoting Activities of Nanochitins: An In Vitro Analysis. (PubMed, Biomacromolecules)
All nanochitin could regulate Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor-7 (FGF-7) secretion, potentially promoting angiogenesis and dermal repair-related biological processes, with hydrochloric acid hydrolyzed nanochitin (HNCh) having the strongest pro-secretory effect, increasing VEGF levels by 30.0%. Moreover, all four types of nanochitin effectively promote hair growth in mice; DNCh and phosphoric acid hydrolyzed nanochitin (PNCh) groups demonstrated superior therapeutic outcomes, with earlier emergence of dense hair shafts compared to HNCh and amphoteric nanochitin (ANCh) groups, while ANCh demonstrated the most balanced and optimal overall effect.
Preclinical • Journal
|
FGF (Fibroblast Growth Factor) • FGF7 (Fibroblast Growth Factor 7)
3ms
Integrated bioinformatics analysis to elucidate cellular communication in the microenvironment of breast cancer. (PubMed, Discov Oncol)
In the tumor microenvironment of breast cancer, intercellular communication pairs of different cell types and molecules can exacerbate the development of breast cancer. among them, through the present study, we found that CXCL12-CXCR4 and FGF7-FGFR1 are the most important. Also, most significantly differentially expressed genes including CHRDL1, SCARA5, LYVE1, PI16, and SAA2 seemed to play a critical role in these mechanisms and immune cell infiltration, shaping the TME of BC.
Journal
|
FGFR1 (Fibroblast growth factor receptor 1) • CXCR4 (Chemokine (C-X-C motif) receptor 4) • CXCL12 (C-X-C Motif Chemokine Ligand 12) • SAA2 (Serum Amyloid A2) • PI16 (Peptidase Inhibitor 16) • FGF7 (Fibroblast Growth Factor 7) • LYVE1 (Lymphatic vessel endothelial hyaluronan receptor 1)
4ms
Identifying Molecular Determinants and Therapeutic Targets in Luminal B Breast Cancer: A Systems Biology Approach. (PubMed, Iran J Pathol)
Further analysis indicated hsa-mir-221-3p and hsa-mir-29a-3p as key miRNAs targeting LBBC-related genes. Collectively, our findings highlighted LBBC-associated genes, TFs, miRNAs, and pathways as prospective biomarkers, providing insights into LBBC diagnosis and therapeutic approaches.
Journal
|
EGFR (Epidermal growth factor receptor) • IGF1 (Insulin-like growth factor 1) • FGF2 (Fibroblast Growth Factor 2) • CDK2 (Cyclin-dependent kinase 2) • MIR221 (MicroRNA 221) • PPARG (Peroxisome Proliferator Activated Receptor Gamma) • CDK1 (Cyclin-dependent kinase 1) • EGR1 (Early Growth Response 1) • FGF7 (Fibroblast Growth Factor 7) • MAPK14 (Mitogen-Activated Protein Kinase 14) • MAPK3 (Mitogen-Activated Protein Kinase 3) • MIR29A (MicroRNA 29a) • RELA (RELA Proto-Oncogene)
5ms
Angptl4 is upregulated by microenvironmental factors during the wound healing process and promotes epidermal stem cell proliferation via PRL8a6. (PubMed, Acta Biochim Biophys Sin (Shanghai))
Knockdown of Angptl4 or Prl8a6 in periwound skin tissue impairs EpSC proliferation and delays wound re-epithelialization. In conclusion, our study demonstrates that, after skin injury, elevated levels of proinflammatory cytokines and growth factors in periwound tissue stimulate Angptl4 expression in EpSCs and that ANGPTL4 promotes EpSC proliferation by increasing Prl8a6 expression, thereby accelerating wound re-epithelialization.
Journal
|
CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • EGF (Epidermal growth factor) • TGFB1 (Transforming Growth Factor Beta 1) • CCNE2 (Cyclin E2) • CDK1 (Cyclin-dependent kinase 1) • IL1B (Interleukin 1, beta) • ANGPTL4 (Angiopoietin Like 4) • FGF7 (Fibroblast Growth Factor 7)
6ms
Molecular crossroads: identifying MAPK proteins bridging SMAD and dopamine pathways in breast cancer. (PubMed, Cell Cycle)
Protein interaction analysis highlighted key hubs linking MAPK, SMAD, and dopamine signaling. This study elucidates crucial molecular intersections between MAPK, SMAD, and dopamine pathways, identifying potential biomarkers and therapeutic targets for breast cancer.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • KRAS (KRAS proto-oncogene GTPase) • IGF1 (Insulin-like growth factor 1) • FGF2 (Fibroblast Growth Factor 2) • TGFB1 (Transforming Growth Factor Beta 1) • MIR221 (MicroRNA 221) • CDC42 (Cell Division Cycle 42) • MIR16 (MicroRNA 16) • FGF7 (Fibroblast Growth Factor 7) • MIR222 (MicroRNA 222)
|
HER-2 positive • HER-2 negative
6ms
Involvement of Hormone Receptors, Membrane Receptors and Signaling Pathways in European Gastric Cancers Regarding Subtypes and Epigenetic Alterations: A Pilot Study. (PubMed, Biomedicines)
Our results also report the strong decreased expression of ERRγ and GPER (two receptors that bind estrogen or xenoestrogens) in diffuse and intestinal subtypes. Our study identified new target genes, namely hormone receptors and membrane receptors (ERRγ and GPER), whose expression is associated with an aggressive phenotype of diffuse GC, and revealed the importance of epigenetic factors (EZH2, HOTAIR, H19 and DNMT1) in gastric cancers.
Journal
|
ER (Estrogen receptor) • PGR (Progesterone receptor) • FGFR1 (Fibroblast growth factor receptor 1) • AR (Androgen receptor) • IGF1 (Insulin-like growth factor 1) • MMP2 (Matrix metallopeptidase 2) • DNMT1 (DNA methyltransferase 1) • HOTAIR (HOX Transcript Antisense RNA) • ZEB2 (Zinc Finger E-Box Binding Homeobox 2) • FGF7 (Fibroblast Growth Factor 7)
6ms
Causal associations between fibroblast growth factors and breast cancer: Evidence from 2-sample Mendelian randomization analysis. (PubMed, Medicine (Baltimore))
Our study results indicate that only specific types of FGFs and FGFRs may have a causal relationship with BC. Th research provides a new perspective on the mechanisms of action of different types of FGFs and FGFRs in BC, and offers potential genetic support for personalized medicine and precision therapy.
Journal
|
FGFR2 (Fibroblast growth factor receptor 2) • FGF4 (Fibroblast growth factor 4) • FGF (Fibroblast Growth Factor) • FGF1 (Fibroblast Growth Factor 1) • FGF23 (Fibroblast Growth Factor 23) • FGF7 (Fibroblast Growth Factor 7)
6ms
Exosome-delivered METTL14 drives hypoxia-induced proliferation, metastasis, and glycolysis of breast cancer cells through regulating TRIM16-mediated FGF7 ubiquitination. (PubMed, Breast Cancer Res)
Hypoxia-induced exosomal METTL14 supports the proliferation, metastasis, and glycolysis of TNBC cells through regulating TRIM16-mediated FGF7 ubiquitination, providing a promising therapeutic target for TNBC treatment.
Journal
|
FGF (Fibroblast Growth Factor) • FTO (Alpha-Ketoglutarate-Dependent Dioxygenase FTO) • CD81 (CD81 Molecule) • FGF7 (Fibroblast Growth Factor 7) • METTL14 (Methyltransferase 14) • METTL3 (Methyltransferase Like 3) • TSG101 (Tumor Susceptibility 101) • WTAP (WT1 Associated Protein)
7ms
Comprehensive genomic profiling and clinico-pathologic characterization of primary ovarian leiomyosarcoma. (PubMed, Int J Gynecol Cancer)
Primary ovarian leiomyosarcomas exhibit a complex genomic landscape marked by genomic instability, sharing key alterations with uterine leiomyosarcomas. TP53 and PTEN mutations may play a central role in their pathogenesis. This first genomic profiling analysis of ovarian leiomyosarcomas provides a basis for further research and potential targeted therapeutic approaches in this rare malignancy.
Journal • Tumor mutational burden • BRCA Biomarker
|
TP53 (Tumor protein P53) • PGR (Progesterone receptor) • TMB (Tumor Mutational Burden) • BRCA2 (Breast cancer 2, early onset) • PTEN (Phosphatase and tensin homolog) • HRD (Homologous Recombination Deficiency) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • CHEK2 (Checkpoint kinase 2) • CHEK1 (Checkpoint kinase 1) • FGF (Fibroblast Growth Factor) • FGF7 (Fibroblast Growth Factor 7)
|
TP53 mutation • PTEN mutation
|
TruSight Oncology 500 Assay
7ms
A ligand-receptor interactome of the bone tumor microenvironment in multiple myeloma bone pain. (PubMed, Pain)
Together, our analysis maps potential nociceptive signaling pathways of different MM microenvironment cell types. These pathways extend from upstream regulatory kinases to transcription factors to secreted ligands, which can potentially stimulate sensory neuron receptors in the bone.
Journal
|
IGF1 (Insulin-like growth factor 1) • MIF (Macrophage Migration Inhibitory Factor) • TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1) • SEMA6A (Semaphorin 6A) • FGF7 (Fibroblast Growth Factor 7) • MAPK14 (Mitogen-Activated Protein Kinase 14) • NRG2 (Neuregulin 2)